当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Alexandre Kirby
Tuberculosis (TB) is a persistent global health concern that can have profound implications for both maternal and fetal health during pregnancy. The physiological changes that occur during pregnancy can complicate the diagnosis and management of TB in expectant mothers. Maternal TB can lead to adverse outcomes such as preterm labor, low birth weight, and maternal mortality. Moreover, the impact of TB on fetal health is increasingly recognized, with risks of intrauterine growth restriction, congenital TB, and stillbirth. This article explores the multifaceted impact of TB on maternal and fetal health, highlighting the challenges of diagnosis and treatment in pregnant women. It underscores the necessity of integrated care approaches involving both obstetric and pulmonary specialties, as well as strategies for prevention and early detection to minimize the detrimental effects of TB on this vulnerable population.